QOSHE - AstraZeneca CEO 'massively underpaid' despite earning double Novo Nordisk boss - Ryan Hogg
menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

AstraZeneca CEO 'massively underpaid' despite earning double Novo Nordisk boss

9 14
10.04.2024
Shareholder advisors are urging investors to vote against Pascal Soriot's proposed $2.3 million raise, arguing it is excessive.

© Fortune


Get it on Google Play